Wen‐Jen Hwu
- Oncology top 1%
- Cancer Immunotherapy and Biomarkers 49
- CAR-T cell therapy research 33
- Cutaneous Melanoma Detection and Management 23
- Colorectal Cancer Treatments and Studies 7
- Immunology top 2%
- Immunotherapy and Immune Responses 27
- Genetics top 5%
-
- Brain Metastases and Treatment 16
- Molecular Biology top 10%
- Melanoma and MAPK Pathways 33
- Protein Degradation and Inhibitors 6
- Co-authors
- Jedd D. WolchokF. Stephen HodiAntoni RibasRichard KeffordAdil DaudMichael A. DaviesJeffrey S. WeberOmid Hamid
- Cited by
- OncologyImmunologyGenetics
- Journals
- Journal of Clinical Oncology (51 papers)SHILAP Revista de lepidopterología (1 paper)Cancer (6 papers)
- Partner nations
- United StatesAustraliaFrance
In The Last Decade
Wen‐Jen Hwu
92 papers receiving 3.1k citations
Hit Papers
Peers
Comparison fields: 5 of 93
- Oncology 2.5k
- Immunology 1.0k
- Genetics 273
- Pulmonary and Respiratory Medicine 780
- Molecular Biology 1.1k
Countries citing papers authored by Wen‐Jen Hwu
This map shows the geographic impact of Wen‐Jen Hwu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wen‐Jen Hwu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wen‐Jen Hwu more than expected).
Fields of papers citing papers by Wen‐Jen Hwu
This network shows the impact of papers produced by Wen‐Jen Hwu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wen‐Jen Hwu. The network helps show where Wen‐Jen Hwu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Wen‐Jen Hwu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 30 | |
| 2 | 2020 | 12 | |
| 3 | 2020 | 2 | |
| 4 | Five-year survival outcomes for patients with advanced melanoma treated with pembrolizumab in KEYNOTE-001breakdown → | 2019 | 638 |
| 5 | 2018 | 48 | |
| 6 | 2017 | 5 | |
| 7 | 2017 | 11 | |
| 8 | 2014 | 11 | |
| 9 | 2013 | 3 | |
| 10 | 2012 | 36 | |
| 11 | 2011 | 46 | |
| 12 | 2010 | 53 | |
| 13 | 2010 | 17 | |
| 14 | 2010 | 387 | |
| 15 | 2010 | 78 | |
| 16 | 2009 | 64 | |
| 17 | 2006 | 38 | |
| 18 | 2005 | 81 | |
| 19 | 2003 | 6 | |
| 20 | 2000 | 7 |
About Wen‐Jen Hwu
Wen‐Jen Hwu is a scholar working on Oncology, Immunology and Pulmonary and Respiratory Medicine, having authored 92 papers that have together received 3.2k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (49 papers), CAR-T cell therapy research (33 papers), Melanoma and MAPK Pathways (33 papers), Immunotherapy and Immune Responses (27 papers), Cutaneous Melanoma Detection and Management (23 papers), Brain Metastases and Treatment (16 papers), Colorectal Cancer Treatments and Studies (7 papers) and Protein Degradation and Inhibitors (6 papers). The work is most often cited by research in Oncology (2.5k citations), Immunology (1.0k citations) and Genetics (273 citations). Wen‐Jen Hwu has collaborated with scholars based in United States, Australia and France. Frequent co-authors include Jedd D. Wolchok, F. Stephen Hodi, Antoni Ribas, Richard Kefford, Adil Daud, Michael A. Davies, Jeffrey S. Weber, Omid Hamid, Caroline Robert and Anthony M. Joshua. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.